# Phase II Trial of Sorafenib Combined With Concurrent HAIC for Hepatocellular Carcinoma

> **NCT02981498** · PHASE2 · COMPLETED · sponsor: **Sun Yat-sen University** · enrollment: 35 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **PROCEDURE:** Hepatic arterial infusion chemotherapy
- **DRUG:** Folfox Protocol

## Key facts

- **NCT ID:** NCT02981498
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2017-04
- **Final completion:** 2017-04
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2019-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02981498

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02981498, "Phase II Trial of Sorafenib Combined With Concurrent HAIC for Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02981498. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*